molsidomine has been researched along with thromboxane a2 in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 7 (63.64) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benveniste, J; Nunez, D; Russo-Marie, F | 1 |
| Berdeaux, A; Giudicelli, JF | 1 |
| Punzengruber, C; Silberbauer, K; Sinzinger, H; Slany, J | 1 |
| Block, HU; Förster, W; Heinroth, I | 1 |
| Armstrong, R; Heptinstall, S; Lösche, W; May, JA | 1 |
| Nam, KY; Park, HJ; Park, KH; Park, KM; Rhee, MH | 1 |
| Fujiwara, Y; Gambone, LM; Murray, PA | 1 |
| Fujioka, M; Isaka, N; Ito, M; Miyahara, M; Nakano, T; Nishikawa, M; Shiku, H | 1 |
| Grimminger, F; Mayer, K; Otterbein, J; Schütte, H; Seeger, W; Spriestersbach, R; Walmrath, D | 1 |
| Bode-Böger, SM; Böger, RH; Frölich, JC; Galland, A | 1 |
| Murakami, Y; Okuma, Y; Osumi, Y; Yokotani, K | 1 |
1 trial(s) available for molsidomine and thromboxane a2
| Article | Year |
|---|---|
Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro.
Topics: Adult; Antithrombins; Arginine; Blood Platelets; Cyclic GMP; Enzyme Inhibitors; Humans; In Vitro Techniques; Infusions, Intravenous; Male; Molsidomine; Nitric Oxide Synthase; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane A2; Thromboxane B2; Thromboxanes | 1998 |
10 other study(ies) available for molsidomine and thromboxane a2
| Article | Year |
|---|---|
[Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
Topics: Animals; Blood Platelets; Molsidomine; Platelet Activating Factor; Platelet Aggregation; Rabbits; Thromboxane A2 | 1987 |
[Redistribution of the coronary blood flow, functional improvement of the ischemic myocardium and reduction of the size of an experimental infarction by molsidomine].
Topics: Animals; Coronary Circulation; Coronary Disease; Dogs; Epoprostenol; Molsidomine; Oxadiazoles; Oxygen Consumption; Platelet Aggregation; Sydnones; Thromboxane A2 | 1983 |
[Molsidomine, a coronary drug with platelet-aggregating inhibitory activity].
Topics: Angina Pectoris; Blood Pressure; Coronary Disease; Epoprostenol; Female; Humans; Male; Molsidomine; Muscle, Smooth, Vascular; Oxadiazoles; Platelet Aggregation; Prostaglandins F; Sydnones; Thromboxane A2; Thromboxane B2 | 1982 |
SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
Topics: Animals; Arachidonic Acids; Blood Platelets; Drug Interactions; Female; Humans; Indoles; Male; Molsidomine; Oxadiazoles; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Pyridines; Rabbits; Sydnones; Thromboxane A2; Thromboxanes | 1982 |
Factors that contribute to spontaneous platelet aggregation and streptokinase-induced aggregation in whole blood.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Hirudins; Humans; Iloprost; Magnesium Chloride; Molecular Sequence Data; Molsidomine; Platelet Aggregation; Platelet Aggregation Inhibitors; Reference Values; Streptokinase; Thromboxane A2 | 1995 |
Effect of non-saponin fraction from Panax ginseng on cGMP and thromboxane A2 in human platelet aggregation.
Topics: Alkynes; Blood Platelets; Calcium; Calcium Channel Blockers; Cyclic AMP; Cyclic GMP; Diynes; Fatty Alcohols; Humans; Molsidomine; Panax; Plant Extracts; Plants, Medicinal; Platelet Aggregation Inhibitors; Thrombin; Thromboxane A2; Vasodilator Agents; Verapamil | 1995 |
Endothelium-dependent pulmonary vasodilation is selectively attenuated during isoflurane anesthesia.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Anesthesia; Animals; Blood Pressure; Bradykinin; Dogs; Dose-Response Relationship, Drug; Endothelium, Vascular; Gases; Halothane; Hemodynamics; Homeostasis; Isoflurane; Male; Molsidomine; Nitroprusside; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; Thromboxane A2; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 1997 |
Characterization of the isoenzymes of cyclic nucleotide phosphodiesterase in human platelets and the effects of E4021.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Blood Platelets; Cyclic Nucleotide Phosphodiesterases, Type 5; Humans; In Vitro Techniques; Isoenzymes; Molsidomine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Phthalazines; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinazolines; Signal Transduction; Thromboxane A2; Tissue Distribution | 1996 |
Efficiency of aerosolized nitric oxide donor drugs to achieve sustained pulmonary vasodilation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Inhalation; Aerosols; Animals; Female; Lung; Male; Molsidomine; Nitric Oxide; Nitroglycerin; Nitroprusside; Prodrugs; Prostaglandin Endoperoxides, Synthetic; Rabbits; Sydnones; Thromboxane A2; Vasodilation | 1997 |
Thromboxane A2 is involved in the nitric oxide-induced central activation of adrenomedullary outflow in rats.
Topics: Animals; Benzoates; Cyclooxygenase Inhibitors; Epinephrine; Imidazoles; Indomethacin; Injections, Intraventricular; Male; Medulla Oblongata; Molsidomine; Nitric Oxide; Norepinephrine; Rats; Rats, Wistar; Receptors, Thromboxane; Superoxide Dismutase; Thromboxane A2; Thromboxane-A Synthase | 1998 |